세계의 중합효소 연쇄 반응(PCR) 기술 시장 보고서(2025년)
Polymerase Chain Reaction (PCR) Technologies Global Market Report 2025
상품코드 : 1825871
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

중합효소 연쇄 반응(PCR) 기술 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 11.1%의 CAGR로 247억 2,000만 달러로 성장할 것입니다. 예측 기간의 성장은 신속하고 정확한 질병 진단에 대한 수요 증가, 법의학에 대한 수요 증가, 실시간 중합효소 연쇄 반응의 채택 확대, 신속한 현장 진단 검사에 대한 수요 증가, 감염성 질환 발생 증가, 동반진단 약품에 대한 수요 증가에 기인할 것으로 예상됩니다. 것으로 판단됩니다. 예측 기간의 주요 동향으로는 차세대 염기서열분석기(NGS) 통합, RNA 검출 및 분석, 단일세포 PCR 분석, 생물정보학 소프트웨어 및 데이터 분석 도구, 미세유체 기술, 랩온칩 시스템, 현장진단 검사(POCT), 인공지능(AI) 및 데이터 분석 등이 있습니다. 분석 등이 있습니다.

향후 5년간 11.1%의 성장률 전망은 지난번 전망치보다 0.9% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 독일과 중국에서 조달하는 중합효소 연쇄 반응 검사 장비 및 시약의 비용을 상승시키고, 진단 처리 시간을 지연시키며, 임상 검사 비용을 상승시켜 미국 시장을 저해할 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

전염병의 확산은 PCR 기술 시장의 향후 성장을 촉진할 것으로 예상됩니다. 감염병이란 세균, 바이러스, 기생충, 곰팡이 등 병원성 미생물에 의해 발생하는 질병을 말하며, 사람에서 사람으로 직간접적으로 전파될 수 있습니다. 감염증의 발병률 증가는 세계화, 도시화, 항균제 내성, 환경 변화 등의 요인에 의해 영향을 받는 것으로 보이는 병원균에 대한 도전이 증가하고 있음을 강조하고 있습니다. PCR 기술은 병원균의 특정 유전물질을 검출 및 증폭하여 고감도, 고정밀도로 식별 및 진단을 용이하게함으로써 감염병 대책에 중요한 역할을 하고 있습니다. 예를 들어, 2023년 11월 스위스에 본부를 두고 국제 공중보건을 담당하는 유엔 전문기구인 세계보건기구(WHO)에 따르면, 2022년에는 전 세계적으로 1,060만 명의 결핵 환자가 발생해 580만 명의 남성, 350만 명의 여성, 130만 명의 어린이가 결핵에 걸릴 것으로 예측하고 있습니다. 따라서 감염성 질환의 유행이 증가하고 있는 것이 PCR 기술 시장을 주도하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Polymerase chain reaction (PCR) technologies are laboratory techniques utilized to amplify and analyze DNA sequences, serving as a cornerstone tool in molecular biology. They find widespread application in genetic testing, diagnostics, forensics, and research.

The primary products associated with PCR technologies include reagents and consumables, instruments, software, and services. Reagents and consumables encompass materials, chemicals, or supplies consumed during scientific experiments, research, or industrial processes. Various PCR technologies are employed, such as real-time PCR, conventional PCR, reverse transcription PCR, digital PCR, multiplex real-time PCR, hot start PCR, among others. These technologies cater to diverse applications including gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point-of-care diagnostics, and environmental applications. End-users of PCR technologies include hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The PCR technologies research report is one of a series of new reports from The Business Research Company that provides PCR technologies market statistics, including the PCR technologies industry's global market size, regional shares, competitors with a PCR technologies market share, detailed PCR technologies market segments, market trends and opportunities, and any further data you may need to thrive in the PCR technologies industry. This PCR technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The polymerase chain reaction (pcr) technologies market size has grown rapidly in recent years. It will grow from $14.58 billion in 2024 to $16.23 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to the increased number of genome-based drug development activities, growth in the prevalence of genetic disorders and target diseases, increased use of miniaturized portable instruments, growth in use of biomarker profiling, and growth in demand for personalized medicine.

The polymerase chain reaction (pcr) technologies market size is expected to see rapid growth in the next few years. It will grow to $24.72 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to a rise in demand for rapid and accurate diagnosis of disease, growing demand for forensics, growing adoption of real-time polymerase chain reaction, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and demand for companion diagnostics. Major trends in the forecast period include next-generation sequencing (NGS) integration, RNA detection and analysis, single-cell PCR analysis, bioinformatics software and data analysis tools, microfluidic technologies, lab-on-a-chip systems, and point-of-care testing (POCT), artificial intelligence (AI) and data analytics.

The forecast of 11.1% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of Polymerase Chain Reaction testing equipment and reagents sourced from Germany and China, thereby delaying diagnostic turnaround times and elevating clinical laboratory expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

An increasing prevalence of infectious diseases is expected to propel the growth of the PCR technologies market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that can spread directly or indirectly from one person to another. The rising incidence of infectious diseases underscores the mounting challenges posed by pathogens, likely influenced by factors such as globalization, urbanization, antimicrobial resistance, and environmental changes. PCR technologies play a crucial role in combating infectious diseases by detecting and amplifying specific genetic material of pathogens, facilitating their identification and diagnosis with high sensitivity and accuracy. For instance, in November 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, 10.6 million cases of tuberculosis (TB) are predicted to occur globally in 2022, affecting 5.8 million men, 3.5 million women, and 1.3 million children. Therefore, the increasing prevalence of infectious diseases is driving the PCR technologies market.

Major companies in the PCR technologies market are dedicated to advancing technological solutions, such as next-gen quantitative polymerase chain reaction (qPCR) technologies, to enhance accuracy, sensitivity, and efficiency in molecular diagnostics. Quantitative polymerase chain reaction (qPCR) technology quantifies specific DNA sequences in samples, offering real-time monitoring and amplification, making it indispensable across scientific and medical disciplines. For instance, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology company, recently introduced the LightCycler PRO System in November 2023. This next-generation qPCR system is designed to meet clinical needs in molecular diagnostics and address public health challenges. It aims to be the most advanced qPCR technology for both clinical diagnostics and research, offering improved performance and usability while bridging the gap between translational research and in vitro diagnostics. Leveraging gold-standard technology, this system ensures quality, precision, and reliability crucial for precise patient diagnosis and informed clinical decisions.

In May 2023, Transformative Biotech LLC, a US-based startup biotechnology company, acquired Summit Biolabs with the aim of implementing rapid and highly accurate direct-to-polymerase chain reaction (PCR) technologies. Summit Biolabs, another US-based biotechnology company, specializes in developing innovative molecular diagnostic solutions and direct-to-PCR technologies, poised to revolutionize the biotechnology industry.

Major companies operating in the polymerase chain reaction (PCR) technologies market are F. Hoffmann-La Roche Ltd., Bayer Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company (BD), GE Healthcare Technologies LLC, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMerieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., Ambry Genetics Corporation, Veritas Genetics Inc.

North America was the largest region in the PCR technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the polymerase chain reaction (PCR) technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The PCR technologies market consists of revenues earned by entities by providing services such as gene expression analysis, pathogen detection, viral load quantification, reverse transcriptase enzyme, custom assay development, clinical diagnostics, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The PCR technologies market also includes sales of thermal cyclers, quantitative polymerase chain reaction (qPCR) instruments, digital polymerase chain reaction systems, reverse transcription polymerase chain reaction (RT-PCR) kits, reagents and consumables, master mixes, polymerase chain reaction plates and tubes, polymerase chain reaction cleanup and purification kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Polymerase Chain Reaction (PCR) Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on polymerase chain reaction (pcr) technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for polymerase chain reaction (pcr) technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The polymerase chain reaction (pcr) technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Polymerase Chain Reaction (PCR) Technologies Market Characteristics

3. Polymerase Chain Reaction (PCR) Technologies Market Trends And Strategies

4. Polymerase Chain Reaction (PCR) Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Polymerase Chain Reaction (PCR) Technologies Growth Analysis And Strategic Analysis Framework

6. Polymerase Chain Reaction (PCR) Technologies Market Segmentation

7. Polymerase Chain Reaction (PCR) Technologies Market Regional And Country Analysis

8. Asia-Pacific Polymerase Chain Reaction (PCR) Technologies Market

9. China Polymerase Chain Reaction (PCR) Technologies Market

10. India Polymerase Chain Reaction (PCR) Technologies Market

11. Japan Polymerase Chain Reaction (PCR) Technologies Market

12. Australia Polymerase Chain Reaction (PCR) Technologies Market

13. Indonesia Polymerase Chain Reaction (PCR) Technologies Market

14. South Korea Polymerase Chain Reaction (PCR) Technologies Market

15. Western Europe Polymerase Chain Reaction (PCR) Technologies Market

16. UK Polymerase Chain Reaction (PCR) Technologies Market

17. Germany Polymerase Chain Reaction (PCR) Technologies Market

18. France Polymerase Chain Reaction (PCR) Technologies Market

19. Italy Polymerase Chain Reaction (PCR) Technologies Market

20. Spain Polymerase Chain Reaction (PCR) Technologies Market

21. Eastern Europe Polymerase Chain Reaction (PCR) Technologies Market

22. Russia Polymerase Chain Reaction (PCR) Technologies Market

23. North America Polymerase Chain Reaction (PCR) Technologies Market

24. USA Polymerase Chain Reaction (PCR) Technologies Market

25. Canada Polymerase Chain Reaction (PCR) Technologies Market

26. South America Polymerase Chain Reaction (PCR) Technologies Market

27. Brazil Polymerase Chain Reaction (PCR) Technologies Market

28. Middle East Polymerase Chain Reaction (PCR) Technologies Market

29. Africa Polymerase Chain Reaction (PCR) Technologies Market

30. Polymerase Chain Reaction (PCR) Technologies Market Competitive Landscape And Company Profiles

31. Polymerase Chain Reaction (PCR) Technologies Market Other Major And Innovative Companies

32. Global Polymerase Chain Reaction (PCR) Technologies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Polymerase Chain Reaction (PCR) Technologies Market

34. Recent Developments In The Polymerase Chain Reaction (PCR) Technologies Market

35. Polymerase Chain Reaction (PCR) Technologies Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기